Hypertension, antihypertensives and mutations in the Von Hippel-Lindau gene in renal cell carcinoma: Results from the Netherlands Cohort Study

Journal of Hypertension

Volumn 23, Issue 11, 2005, Pages 1997-2004

  Schouten, Leo J ^a,d   Van Dijk, Boukje A C ^a   Oosterwijk, Egbert ^b   Hulsbergen van De Kaa, Christina A ^b   Kiemeney, Lambertus A L M ^b   Goldbohm, R Alexandra ^c   Schalken, Jack A ^b   Van Den Brandt, Piet A ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c TNO   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Antihypertensive medication; Cohort study; Hypertension; Renal cell carcinoma; The Netherlands; VHL mutations

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIURETIC AGENT; PARAFFIN; VON HIPPEL LINDAU PROTEIN;

ADULT; AGED; ARTICLE; BODY MASS; CANCER RISK; CIGARETTE SMOKING; COHORT ANALYSIS; DNA ISOLATION; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC RISK; HUMAN; HYPERTENSION; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PRIORITY JOURNAL;

EID: 29244458646     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000186023.74245.48     Document Type: Article

References (42)

1. Grossman E, Messerli FH, Goldbourt U. Does diuretic therapy increase the risk of renal cell carcinoma? [editorial; see comments]. Am J Cardiol 1999; 83:1090-1093.
2. Grossman E, Messerli FH, Boyko V, Goldbourt U. Is there an association between hypertension and cancer mortality? Am J Med 2002; 112:479-486.
3. McLaughlin JK, Chow WH, Mandel JS, Mellemgaard A, McCredie M, Lindblad P, et al. International renal-cell cancer study. VIII. Role of diuretics, other anti-hypertensive medications and hypertension. Int J Cancer 1995; 63:216-221.
4. Shapiro JA, Williams MA, Weiss NS, Stergachis A, LaCroix AZ, Barlow WE. Hypertension, antihypertensive medication use, and risk of renal cell carcinoma. Am J Epidemiol 1999; 149:521-530.
5. Chow WH, Gridley G, Fraumeni JF Jr, Jarvholm B. Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med 2000; 343:1305-1311.
6. Rosengren A, Himmelmann A, Wilhelmsen L, Branehog I, Wedel H. Hypertension and long-term cancer incidence and mortality among Swedish men. J Hypertens 1998; 16:933-940.
7. Mellemgaard A, Moller H, Olsen JH. Diuretics may increase risk of renal cell carcinoma. Cancer Causes Control 1992; 3:309-312.
8. Heath CW Jr, Lally CA, Calle EE, McLaughlin JK, Thun MJ. Hypertension, diuretics, and antihypertensive medications as possible risk factors for renal cell cancer. Am J Epidemiol 1997; 145:607-613.
9. Grove JS, Nomura A, Severson RK, Stemmermann GN. The association of blood pressure with cancer incidence in a prospective study. Am J Epidemiol 1991; 134:942-947.
10. Coughlin SS, Neaton JD, Randall B, Sengupta A. Predictors of mortality from kidney cancer in 332,547 men screened for the Multiple Risk Factor Intervention Trial. Cancer 1997; 79:2171-2177.
11. Prineas RJ, Folsom AR, Zhang ZM, Sellers TA, Potter J. Nutrition and other risk factors for renal cell carcinoma in postmenopausal women. Epidemiology 1997; 8:31-36.
12. Fraser GE, Phillips RL, Beeson WL. Hypertension, antihypertensive medication and risk of renal carcinoma in California Seventh-Day Adventists. Int J Epidemiol 1990; 19:832-838.
13. Kovacs G, Akhtar M, Beckwith BJ, Bugert P, Cooper CS, Delahunt B, et al. The Heidelberg classification of renal cell tumours [editorial]. J Pathol 1997; 183:131-133.
14. Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, et al. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 1994; 7:85-90.
15. Cohen HT. Advances in the molecular basis of renal neoplasia. Curr Opin Nephrol Hypertens 1999; 8:325-331.
16. Brauch H, Weirich G, Hornauer MA, Storkel S, Wohl T, Bruning T. Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma. J Natl Cancer Inst 1999; 91:854-861.
17. Hemminki K, Jiang Y, Ma X, Yang K, Egevad L, Lindblad P. Molecular epidemiology of VHL gene mutations in renal cell carcinoma patients: relation to dietary and other factors. Carcinogenesis 2002; 23:809-815.
18. Gago-Dominguez M, Castelao JE, Yuan JM, Ross RK, Yu MC. Lipid peroxidation: a novel and unifying concept of the etiology of renal cell carcinoma (United States). Cancer Causes Control 2002; 13:287-293.
19. Van den Brandt PA, Goldbohm RA, Van't Veer P, Volovics A, Hermus RJ, Sturmans F. A large-scale prospective cohort study on diet and cancer in The Netherlands. J Clin Epidemiol 1990; 43:285-295.
20. Volovics A, van den Brandt PA. Methods for the analyses of case-cohort studies. Biom J 1997; 39:159-214.
21. Van den Brandt PA, Schouten LJ, Goldbohm RA, Dorant E, Hunen PM. Development of a record linkage protocol for use in the Dutch Cancer Registry for Epidemiological Research. Int J Epidemiol 1990; 19:553-558.
22. Goldbohm RA, Van den Brandt PA, Dorant E. Estimation of the coverage of Dutch municipalities by cancer registries and PALGA based on hospital discharge data. Tijdschr Soc Gezondheidsz 1994; 72:80-84.
23. Van Houwelingen KP, van Dijk BA, Hulsbergen-van de Kaa CA, Schouten LJ, Gorissen HJ, Schalken JA, et al. Prevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma: results from The Netherlands cohort study. BMC Cancer 2005; 5:57.
24. Eble J, Sauter G, Epstein J, Sesterhenn I. World Health Organization classification of tumours. Pathology and genetics. Tumours of the urinary system and male genital organs. Lyon: IARC Press; 2004.
25. Goldbohm RA, van den Brandt PA, Brants HA, van't Veer P, Al M, Sturmans F, Hermus RJ. Validation of a dietary questionnaire used in a large-scale prospective cohort study on diet and cancer. Eur J Clin Nutr 1994; 48:253-265.
26. Van den Brandt PA, Petri H, Dorant E, Goldbohm RA, Van de Crommert S. Comparison of questionnaire information and pharmacy data on drug use. Pharm Weekbl (Sci) 1991; 13:91-96.
27. Anonymous. About the ATC/DDD System. Oslo, Norway: WHO Collaborating Centre for Drug Statistics Methodology; 2004.
28. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika 1982; 69:239-241.
29. Lin DY, Wei LJ. The robust inference for the Cox Proportional Hazards Model. J Am Stat Assoc 1989; 84:1074-1078.
30. Van den Brandt PA, van't Veer P, Goldbohm RA, Dorant E, Volovics A, Hermus RJ, Sturmans F. A prospective cohort study on dietary fat and the risk of postmenopausal breast cancer. Cancer Res 1993; 53:75-82.
31. Hoppin JA, Tolbert PE, Taylor JA, Schroeder JC, Holly EA. Potential for selection bias with tumor tissue retrieval in molecular epidemiology studies. Ann Epidemiol 2002; 12:1-6.
32. Giles WH, Croft JB, Keenan NL, Lane MJ, Wheeler FC. The validity of self-reported hypertension and correlates of hypertension awareness among blacks and whites within the stroke belt. Am J Prev Med 1995; 11:163-169.
33. Vargas CM, Burt VL, Gillum RF, Pamuk ER. Validity of self-reported hypertension in the National Health and Nutrition Examination Survey III, 1988-1991. Prev Med 1997; 26:678-685.
34. Boudreau DM, Daling JR, Malone KE, Gardner JS, Blough DK, Heckbert SR. A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older women. Am J Epidemiol 2004; 159:308-317.
35. Kreiger N, Marrett LD, Dodds L, Hilditch S, Darlington GA. Risk factors for renal cell carcinoma: results of a population-based case-control study. Cancer Causes Control 1993; 4:101-110.
36. Weinmann S, Glass AG, Weiss NS, Psaty BM, Siscovick DS, White E. Use of diuretics and other antihypertensive medications in relation to the risk of renal cell cancer. Am J Epidemiol 1994; 140:792-804.
37. Chow WH, McLaughlin JK, Mandel JS, Wacholder S, Niwa S, Fraumeni JF. Jr. Risk of renal cell cancer in relation to diuretics, antihypertensive drugs, and hypertension. Cancer Epidemiol Biomarkers Prev 1995; 4:327-331.
38. Finkle WD, McLaughlin JK, Rasgon SA, Yeoh HH, Low JE. Increased risk of renal cell cancer among women using diuretics in the United States. Cancer Causes Control 1993; 4:555-558.
39. Hiatt RA, Tolan K, Quesenberry CP. Jr. Renal cell carcinoma and thiazide use: a historical, case-control study (California, USA). Cancer Causes Control 1994; 5:319-325.
40. Novick AC, Campbell SC. 75. Renal tumors. In: Walsh PC, Retik AB, Darracott Vaughan E Jr, Wein AJ, Kavoussi LR, Novick AC, et al., editors. Campbell's urology. 8th ed. Philadelphia: Saunders; 2002. pp.2672-2719.
41. Yuan JM, Castelao JE, Gago Dominguez M, Ross RK, Yu MC. Hypertension, obesity and their medications in relation to renal cell carcinoma. Br J Cancer 1998; 77:1508-1513.
42. Rosenberg L, Rao RS, Palmer JR, Strom BL, Stolley PD, Zauber AG, et al. Calcium channel blockers and the risk of cancer. JAMA 1998; 279:1000-1004.